What the FDA labels say about taking them together
Rifampin and seladelpar lysine
Seladelpar lysine's FDA label of February 3, 2026 names rifampin in its drug interactions section; the rifampin label PlainMeds reads does not name seladelpar lysine. The seladelpar lysine label: “Monitor for adverse effects. Rifampin: Monitor biochemical response (e.g., ALP and bilirubin) when patients initiate rifampin.”
Check it at the source: the rifampin FDA label on DailyMed (effective February 11, 2026, Lupin Pharmaceuticals, Inc.); the seladelpar lysine FDA label on DailyMed (effective February 3, 2026, Gilead Sciences, Inc).
What does the rifampin label say about seladelpar lysine?
Rifampin's label (effective February 11, 2026) does not name seladelpar lysine in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (rifampin), Lupin Pharmaceuticals, Inc., effective February 11, 2026 (SPL set b56004f0-f23d-47f6-80c7-39884fccbccc), via openFDA; the full label on DailyMed
What does the seladelpar lysine label say about rifampin?
Seladelpar lysine label, drug interactionsMonitor for adverse effects. ( 7.1 ) Rifampin: Monitor biochemical response (e.g., ALP and bilirubin) when patients initiate rifampin.
Source: FDA drug label (Livdelzi), Gilead Sciences, Inc, effective February 3, 2026 (SPL set 89f79d98-135c-40b2-a585-6996c04e599c), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Rifampin | Seladelpar lysine | |
|---|---|---|
| Labeled for | n/a | n/a |
| Boxed warning | No | No |
| Pharmacy cost (NADAC) | $0.679 per capsule 300 mg capsule | n/a |
| Shortage now | In shortage | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once